CIK 0001581280
- Large accelerated filer
Twist Bioscience Corp
Sign in to watch- Ticker
- TWST
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 462058888
- Phone
- +1 800-719-0671
- Business address
- 681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA, 94080
- 4 Open-market sale Chief Accounting Officer sold 800 shares at $62.48 ($49,987)
- 4 Open-market sale SVP of Human Resources sold 1,399 shares at $53.26 ($74,507)
- 4 Open-market sale President and COO sold 4,160 shares at $53.26 ($221,549)
- 4 Open-market sale See Remarks sold 1,642 shares at $53.26 ($87,448)
- 4 Open-market sale Chief Accounting Officer sold 688 shares at $53.26 ($36,641)
- 4 Open-market sale Chief Executive Officer sold 6,888 shares at $53.26 ($366,834)
- 4 Open-market sale Chief Financial Officer sold 2,019 shares at $53.26 ($107,526)
- 4 Open-market sale Director sold 12,000 shares at $56.12 ($673,440)
- 4 Open-market sale Chief Accounting Officer sold 4,961 shares at $56.88 ($282,187)
- 4 Open-market sale See Remarks sold 1,962 shares at $57.15 ($112,126)
- 4 Open-market sale Chief Executive Officer sold 5,127 shares at $57.15 ($293,002)
- 4 Open-market sale President and COO sold 2,844 shares at $57.15 ($162,531)
- 4 Open-market sale SVP of Human Resources sold 1,116 shares at $57.15 ($63,778)
- 4 Open-market sale Chief Accounting Officer sold 164 shares at $57.15 ($9,372)
- 4 Planned sale Director sold 500 shares at $61.83 ($30,915)
- 4 Open-market sale President and COO sold 2,321 shares at $60.76 ($141,026)
- 4 Planned sale Chief Executive Officer sold 9,671 shares at an average $65.24 ($630,957)
- 4 Planned sale Chief Financial Officer sold 4,000 shares at $60.00 ($240,000)
- 4 Planned sale Chief Financial Officer sold 3,000 shares at $55.00 ($165,000)
- 4 Open-market sale Chief Financial Officer sold 2,597 shares at $49.89 ($129,562)
Page 4 of 51 · 1,011 filings